Experienced clinical research professional and nurse. Working with a network of clinical trial sites to deliver innovative & regionally relevant clinical trials to our local communities. Collaborating with all industry stakeholders to forge a future where innovative treatments, therapies and trials are accessible for all.

Professor Karen Woolley is honoured to be a Life Member of ARCS and served ARCS as a Director and Chair of the Board. As a bereaved parent, clinical trial participant, and caregiver to immediate family members with acute and chronic conditions, Karen’s lived experience has motivated her to work with patients - as partners - in her medical communications career. With patient leaders in the Asia Pacific, European, and North American regions and her medical communication colleagues, she has conducted, presented, and published award-winning research on the ethical and effective involvement of patients in publications. This research has led to practical outcomes with the co-creation of free, evidence-based, online resources for plain language summaries of publications (www.envisionthepatient.com/plstoolkit) and for patient authorship www.patientauthorship.com/). Karen is a Professor at two universities, she has served on the Boards of government hospital and healthcare services (serving 400,000 patients) and not-for-profit research and medical communication associations, she has authored the Good Publication Practice 3 guidelines, prepared Position Statements on the ethical use of professional medical writers for European, American, and international not-for-profit associations, and served on the Editorial Board for an international research integrity journal. To renew her energy, she surfs, runs, cycles, and stairclimbs with (mostly) willing family and friends.

A/Prof Tina Soulis has over 28 years of working in the healthcare (pharmaceuticals and devices), biotechnology, academic research, clinical research and management sectors in senior roles including: CEO of a Contract Research Organization, Director of a successful ASX200 company, VP of Clinical Strategy and Development with an innovative biotechnology company and now, Founder and Director of her own full-service capability clinical CRO. A dynamic and strategic leader, Tina has an extensive network of stakeholders all over the world and experience in many therapeutic areas across all phases on development. Tina holds academic appointments with: * University of Melbourne (teaching and supporting undergraduate pharmacology, Masters in Leadership in Science and Master in Commercialization in Science students) Passionate about mentoring future industry leaders and advocating for the Australian R&D community, Tina serves on several therapeutic executive advisory boards, as Australian resident director to a portfolio of overseas entities and advisors many US-based biotechnology companies. Tina is one of the few Australian clinical development leaders who has successfully taken products from lab to regulatory approval.

Dr Peter de Wet works as a clinical investigator and general practitioner on the Sunshine Coast in Queensland. He has been Principle Investigator on numerous studies at all phases and across a breadth of indications. He maintains a particular interest in rheumatology and geriatric medicine.